Reno Chemicals Pharmaceuticals And Cosmetics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 52 Year, 8 Months
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 2.44 M
- Revenue Growth 1600.00%
- Profit Growth -23.78%
- Ebitda 18.14%
- Net Worth -105.13%
- Total Assets 8.57%
About Reno Chemicals Pharmaceuticals And Cosmetics
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24110MH1972PTC015839
- Company No.
015839
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jun 1972
- Date of AGM
18 Jun 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Reno Chemicals Pharmaceuticals And Cosmetics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harish Lade  | Director | 12-Dec-2017 | Current |
| Jeyamurugan Ramalingam | Director | 12-Dec-2017 | Current |
| Aashish Kshetry | Director | 06-May-2019 | Current |
Financial Performance of Reno Chemicals Pharmaceuticals And Cosmetics.
Reno Chemicals Pharmaceuticals And Cosmetics Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 1600% increase. The company also saw a substantial fall in profitability, with a 23.78% decrease in profit. The company's net worth observed a substantial decline by a decrease of 105.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reno Chemicals Pharmaceuticals And Cosmetics?
In 2021, Reno Chemicals Pharmaceuticals And Cosmetics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Asian Paints Ppg Private LimitedJeyamurugan Ramalingam is a mutual person
Ppg Asian Paints Private LimitedJeyamurugan Ramalingam is a mutual person
Maxbhumi Developers LimitedJeyamurugan Ramalingam, Harish Lade and 1 more are mutual person
Charges (Loans)
₹0
₹2.44 M
Charges Breakdown by Lending Institutions
- Bank Of India : 0.24 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Apr 1979 | Bank Of India | ₹2.00 M | Satisfied |
| 21 Oct 1974 | Bank Of India | ₹0.44 M | Satisfied |
How Many Employees Work at Reno Chemicals Pharmaceuticals And Cosmetics?
Unlock and access historical data on people associated with Reno Chemicals Pharmaceuticals And Cosmetics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reno Chemicals Pharmaceuticals And Cosmetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reno Chemicals Pharmaceuticals And Cosmetics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
